Weight-Loss drug investigated as potential mood booster
NCT ID NCT07136714
Summary
This study is testing if a weekly injection of semaglutide, a medication known for weight loss, can help improve mood when added to usual depression treatment. It will involve 116 adults with major depression who also have overweight or obesity. Participants will receive either the real medication or a placebo (dummy injection) for 26 weeks to see which group reports better improvement in their depression symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mental Health Centre North Zealand
RECRUITINGHillerød, Denmark, 3400, Denmark
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.